Moderna CEO defends pandemic prep efforts with critics set to enter Trump’s administration

Moderna CEO Stéphane Bancel argued that the drug industry’s efforts to prepare for a future pandemic are meant to protect Americans, defending the sector’s work …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Medicare already covers GLP-1s for half of seniors with obesity, new report finds

WASHINGTON — A new report from congressional budget experts this week estimated that it would cost Medicare an additional $35 billion over nine years if the

October 9, 2024

Relief Therapeutics Receives Notice of Allowance for European Patent Covering RLF-TD011 for Epidermolysis Bullosa Wound Treatment – Biotech Investments

Relief Therapeutics Holding SA / Key word(s): Patent 21-Oct-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer

October 22, 2024

ImmunoGen, ImmunoBiochem partner for ADCs development

ImmunoGen and ImmunoBiochem will work together to develop next-generation antibody-drug conjugates. Credit: Alpha Tauri 3D Graphics. ImmunoGen has signed a multi-target licence and option agreement

July 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.